Both human and mouse c-kit ligand induced differentiation of human mast cells in a long-term culture ofthe mononuclear cells of umbilical cord blood. Growth factor activity for human mast cells present in conditioned medium of BALB/3T3 fibroblasts was due to mouse c-kit ligand. Recombinant c-kit ligand induced differentiation and proliferation of mast cell progenitors in early stages of culture. However, apparent selective growth of mast cells by c-kit ligand in cord blood cell cultures is mainly due to the effect of the cytokine to selectively maintain survival of immature mast cells. Electron microscopic analysis indicated that human mast cells developed by c-kit ligand were similar to human mast cells in the lung and gut mucosa, while those developed in coculture of cord blood cells with Swiss albino/3T3 fibroblasts were similar to skin mast cells. This conclusion was supported by the fact that the majority of mast cells developed by c-kit ligand contained only tryptase in their granules, whereas those developed in the cocultures contained both tryptase and chymase. It was also found that mast cells developed by c-kit ligand were immature even after culture for 14 weeks. Nevertheless, these cells express FceRI, and could be sensitized with human IgE for anti-IgE-induced release of histamine, prostaglandin D2, and leukotriene C4.
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Several murine cytokines, such as interleukin (IL)-3, IL4, IL-9, and IL-10 promote differentiation and proliferation of mouse mast cells (1) (2) (3) (4) . In contrast, reproducible growth of human mature mast cells had not been achieved until 1989, when we succeeded in developing morphologically and functionally mature human mast cells in a long-term coculture of mononuclear cells of cord blood with Swiss albino/3T3 fibroblasts (5) . Subsequent studies revealed that the culture supernatant of 3T3 fibroblasts contained growth factors that promote differentiation of human mast cells (6) . Human mast cell growth-promoting activity could be enriched by fractionation of the culture supernatant with ammonium sulfate precipitation and by ion-exchange chromatography. The molecular size of the factor was estimated by gel filtration to be between 70 and 100 kDa (7) .
While our studies were in progress, a cytokine, c-kit ligand, was characterized and molecular cloning of the cytokine has been accomplished by several groups of investigators (8) (9) (10) (11) (12) . The present experiments show that both human and murine c-kit ligand induce differentiation of cord blood cells to human mast cells in culture and provide evidence that human mast cell growth-promoting activity in culture supernatants of 3T3 fibroblasts is associated with murine c-kit ligand.
MATERIALS AND METHODS
Cell Cutures and Microscopic Examination. Mononuclear cells were obtained from heparinized umbilical cord blood (5) and suspended in RPMI 1640 medium (GIBCO) supplemented with 10%o fetal bovine serum (FBS; GIBCO), 50 ,M 2-mercaptoethanol, 2 mM L-glutamine, 100 units of penicillin per ml, 50 ,ug of streptomycin per ml, and 25 ,ug of gentamicin per ml. The cell suspensions were seeded in 2-ml culture wells at a density of 1.5 x 106 cells per ml and were cultured with an appropriate growth factor(s). Half of the culture medium was replaced once a week with freshly prepared medium containing the same concentration of growth factor. Some of the cell suspensions were cocultured with Swiss albino/3T3 fibroblasts (5) and cells were recovered by treatment with 0.25% trypsin/1 mM EDTA at 37°C for 5 min.
Cells developed in the cultures were characterized by staining with May-Grunwald and Giemsa reagents. The metachromatic granule-containing cells were identified by staining with toluidine blue. For electron microscopy, nonadherent cells were fixed in a dilute mixture of aldehydes, washed in 0.1 M sodium cacodylate buffer, and spun through molten agar to form agar blocks containing the cells. The blocks were processed for electron microscopic studies as described (13) .
Growth Factors. Recombinant human stem cell factor/c-kit ligand (rhSCF) and recombinant mouse mast cell growth factor/c-kit ligand (rmMGF) were supplied by Amgen and Immunex, respectively. rh IL-3 and IL-4 were generous gifts of Naoko Arai (DNAX). Human mast cell growth factors (HMGFs) from murine fibroblasts were obtained from a culture supernatant of BALB/3T3 fibroblast cell line cells (ATCC.CCL163, clone A31), which were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10%o FBS, 2 mM L-glutamine, and antibiotics. To obtain serum-free conditioned medium, cells were grown in the medium to confluence, and the medium was replaced with serum-free DMEM containing 5 ,ug of insulin per ml, 5 ,ug of transferrin per ml, and 5 ng of sodium selenite per ml. After 3 days in culture, the supernatant was recovered and concentrated. HMGF in the preparation was partially purified by chromatography on a DEAE-Sepharose CL-6B (Pharmacia) column (7) . The 
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and proteins precipitated between 50% and 70%A saturated ammonium were used as a HMGF-enriched fraction.
Imninglobul n. Human E myeloma protein and rabbit anti-IgE antiserum were prepared as described (14) . Purified IgE (>99%0o pure) was labeled with 1251 using Bolton-Hunter reagent (Amersham). The proportion of 125I-labeled IgE that can bind to human FcERI was determined by the method of Kulczycki and Metzger (15) , using CHO-3D10 cells, a permanent line of cells expressing the chimeric a subunit of human FceRI (16) . The murine monoclonal antibody YB5.B8 (17) , which is specific for human c-kit (18) , and VIM12, which recognizes human basophil surface markers (19) , were used for immunofluorescence. Rabbit antiserum against mouse c-kit ligand was supplied by Immunex. IgG in the antiserum was purified with protein A-Sepharose and 13 mg of the protein was coupled to 1 ml of Affi-Gel 10 (Bio-Rad).
Cytochemical Techniques. Tryptase and chymase in granules of cultured mast cells were identified by sequential double immunohistochemical labeling procedures with biotinylated murine monoclonal anti-chymase antibody (B7-B) and anti-tryptase antibody (G3) coupled to alkaline phosphatase (20) . Chymase-containing granules were stained reddishbrown, while those containing tryptase but not chymase were stained blue (21) .
Incorporation of bromodeoxyuridine (BrdU) into tryptasepositive cells was examined by a double-staining technique.
BrdU was added to cultures at 10 A.M, and cells were recovered after 3 hr of incubation at 37°C. Cytocentrifuge preparations were fixed in Carnoy's fluid, and mast cells in the slides were identified by staining tryptase with monoclonal anti-tryptase antibody and a histostain-SP kit (Zymed Laboratories). The slides were then treated with 0.07 M NaOH for 2 min, and BrdU was stained with monoclonal anti-BrdU antibody (Becton Dickinson) and an ABC alkaline phosphatase staining kit (Pierce). Incorporation of BrdU was evaluated by the presence of blue deposits in the nucleus.
Binding of IgE to Cultured Mast Cells. FceRI on cultured mast cells was detected by immunofluorescence with human IgE and rabbit anti-IgE antibodies (5) . The number of IgE molecules bound to cultured mast cells was estimated from direct binding of 1251-labeled IgE to mast cells as described by Kulczycki and Metzger (15) .
Analysis of Mediators Released from Mast Cells. Cultured cells were incubated with IgE (10 ,ug/ml) overnight at 37°C. After washing, the cells were incubated for 40 min with an optimum concentration (4.5 ,ug/ml) of anti-IgE antibody. Histamine content in supernatants and that remaining in cell pellets were determined by the automated technique of Siraganian (22) . Prostaglandin D2 and leukotrienes C4 and B4 were determined by radioimmunoassay kits from Amersham. Our previous studies have shown that neither human IL-3 nor IL4 induced differentiation of human mast cells in cord blood cell cultures (25) . Thus, to determine whether IL-3 or IL4 might enhance differentiation of mast cells by rhSCF, mononuclear cells of cord blood were cultured for 6 weeks with rhSCF (50 ng/ml) in the presence or absence of rhIL-3 (20 units/ml) and/or rhIL-4 (50 units/ml). Neither IL-3 nor IL-4 significantly affected rhSCF-induced development of human mast cells. The results also confirmed that IL-3 induced differentiation of basophilic granulocytes but not of mast cells.
Development of human mast cells by mouse c-kit ligand suggested the possibility that HMGF from BALB/3T3 fibroblasts is c-kit ligand. To test this possibility, a DEAE fraction containing the growth factors was fractionated on anti-c-kit ligand-coupled Affi-Gel. Preliminary experiments confirmed that the fraction was comparable to mouse c-kit ligand (3-5 ,ug/ml) in terms of the capacity to induce incorporation of [3H]thymidine into P1-18 cells and that 1 ml of the immunosorbent completely absorbed 4 ,ug of mouse c-kit ligand. Thus, a 2-ml aliquot of the DEAE fraction was mixed overnight with 1 ml of the immunosorbent at 4°C, and unbound protein fraction, washing, and acid eluate fractions Table 3 indicate that the major growth-promoting activity in the supernatant of BALB/3T3 fibroblasts is associated with mouse c-kit ligand.
To detect the proliferation/differentiation of immature mast cells by c-kit ligand, we examined possible incorporation of BrdU into tryptase-positive cells during cord blood cell cultures. In the experiments shown in Table 4 , two specimens of cord blood cells were cultured in the presence ofrhSCF (50 ng/ml) and the number oftryptase-positive cells that incorporated BrdU into their nuclei was enumerated. The results showed that 5-30.6% of tryptase-positive cells incorporated BrdU during the initial 2-4 weeks ofculture, but BrdU-positive mast cells were only 0.5-1.4% of total cells during this period. Incorporation of BrdU into mast cells was rarely detected after 6 weeks. It was also noted that the majority of BrdU-positive cells at 2-3 weeks (10-20%6 oftotal cells) did not contain tryptase. Similar results were obtained when cord blood cells were cultured with partially purified HMGF from BALB/3T3 fibroblasts. These findings indicated that both human and mouse c-kit ligand induced proliferation of tryptase-positive cells during an early stage of culture, but the proliferative effect of this cytokine is not selective for mast cell lineage.
Morphological Properties of Mast Cells Developed by Soluble Growth Factors. When the mononuclear cells from cord blood were cultured with a HMGF-enriched fraction or rhSCF (50 ng/ml) for 8-12 weeks, purity and yield of mast cells recovered from the cultures varied depending on the cord blood specimens used. Under the appropriate conditions, however, 1-1.6 x 105 mast cells could be recovered after 8 weeks of culture of 1.5 x 106 mononuclear cells. All of the cultured mast cells were stained with toluidine blue at low pH. They were formaldehyde-sensitive cells and were stained with Alcian blue but not with safranin. It was also found that the majority of mast cells obtained between 6 and 12 weeks in culture could be stained with monoclonal antibody YB5.B8, which is specific for human c-kit (18) but failed to be stained with the monoclonal antibody VIM12, which recognizes human basophil surface components. It was also found that staining the cells with YB5.B8 was prevented by preincubating the cells with rh SCF (50 ng/ml) for 1 hr at 37°C. The results indicated that cultured human mast cells express c-kit on their surface.
The ultrastructure of mast cells developed in the cultures was analyzed. Aliquots of mononuclear cells from the same cord blood were cultured either with a HMGF-enriched cells actually demonstrated that c-kit ligand induced proliferation of immature mast cells and their progenitors during the initial 2-4 weeks of culture. However, the proliferative activity of this cytokine was not selective for mast cell lineage. During the same culture period, a majority of BrdUpositive cells were tryptase-negative cells. It was also found that the number of mast cells in the cultures reached maximum by 6-8 weeks and incorporation of BrdU into mast cells was rarely detected beyond this stage. The reason for a substantial increase in the proportion of mast cells between 6 and 14 weeks is that many of the other cells did not survive in the presence of c-kit ligand. Thus, the major effect of c-kit ligand was to selectively maintain immature mast cells in the cultures. It is not known why c-kit ligand induces proliferation of immature mast cells and their progenitors in the early stages of culture but merely maintains the survival of such mast cells at later stages.
Unique observations obtained in the present experiments were ultrastructural differences between mast cells developed in cocultures of cord blood cells with 3T3 fibroblasts and those developed in the presence ofc-kit ligand. Mast cells developed in the cocultures were similar to mature skin mast cells in both ultrastructural criteria and neutral protease(s) associated with their granules (5) . In contrast, mast cells developed by c-kit ligand were more like those in lung and intestinal mucosa. The majority ofmast cells developed in the latter cell cultures contained only tryptase. It was noted by electron microscopy that these cells were immature even after 14 weeks ofculture. It is quite possible that an additional maturation or differentiation factor(s) is associated with plasma membranes of fibroblasts. It is also possible that the two subsets of mast cells have separate progenitors and that differentiation of skin mast cell progenitors requires a membrane-associated cytokine(s) different from c-kit ligand and/or direct contact with fibroblasts. Nevertheless, our experiments indicate that the two subsets of mast cells can be developed in cultures of cord blood cells under different conditions. In spite of substantial differences between the two subsets in ultrastructural criteria and in maturation, no significant functional differences were detected between the two types of mast cells developed in cultures. The results suggest that the mast cells developed by c-kit ligand are useful for biochemical studies of mediator release from human mast cells.
